221 related articles for article (PubMed ID: 1660321)
1. Nitrovasodilators and cGMP inhibit human platelet activation.
Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside.
Doni MG; Deana R; Padoin E; Ruzzene M; Alexandre A
Biochim Biophys Acta; 1991 Sep; 1094(3):323-9. PubMed ID: 1655043
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside.
Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A
Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
Wu CC; Ko FN; Teng CM
Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
8. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
Zhang Y; Islam M; Akhtar RA
Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
[TBL] [Abstract][Full Text] [Related]
11. Efflux of cyclic GMP from activated human platelets.
Wu XB; Brüne B; Von Appen F; Ullrich V
Mol Pharmacol; 1993 Apr; 43(4):564-8. PubMed ID: 8386309
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
14. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
15. Staurosporine-independent platelet aggregation induced by the calcium ionophore ionomycin is inhibited by prostacyclin and sodium nitroprusside and stimulated by adrenaline.
Doni MG; Alexandre A; Padoin E; Francesconi MA; Deana R
Arch Biochem Biophys; 1993 Mar; 301(2):431-8. PubMed ID: 7681663
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
17. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
18. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.
Deana R; Ruzzene M; Doni MG; Zoccarato F; Alexandre A
Biochim Biophys Acta; 1989 Nov; 1014(2):203-6. PubMed ID: 2573392
[TBL] [Abstract][Full Text] [Related]
20. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
Crane MS; Rossi AG; Megson IL
Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
